Smith & Nephew (SN) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
7 Jan, 2026Executive summary
Achieved 8.3% underlying growth in Q4 and 5.3% for the full year 2024, with all business units contributing.
12-Point Plan drove operational improvements, innovation, and margin expansion, with 60 basis points of trading margin growth and 95% cash conversion.
U.S. market performance was strong, while China remained a significant headwind, impacting group growth by 280 basis points in Q4.
ROIC improved to 7.4%, with further gains expected as restructuring and cost-saving initiatives continue.
Four consecutive years of above-average revenue growth, underpinned by innovation and improved commercial execution.
Financial highlights
Full year revenue reached $5.81 billion, up 5.3% underlying and 4.7% reported; excluding China, underlying growth was 6.7%.
Trading profit rose 8.2% to $1.05 billion; trading margin expanded 60 basis points to 18.1%.
Adjusted EPS grew 1.7% to $0.843; IFRS EPS rose more sharply due to lower restructuring charges.
Free cash flow increased to $551 million, with trading cash conversion at 95%.
Net debt reduced to $2.7 billion; leverage ratio at 1.9x Adjusted EBITDA.
Outlook and guidance
2025 guidance: ~5% underlying revenue growth, trading margin between 19%-20%.
Margin expansion to be driven by operating leverage, cost savings, and manufacturing network optimization, especially in H2.
China remains a headwind, with 150 basis points drag on group growth expected and one fewer trading day in 2025.
Continued margin accretion anticipated in 2026 and 2027.
Latest events from Smith & Nephew
- Strong FY 2025 growth, margin expansion, and new strategy set stage for accelerated 2026 performance.SN
Investor presentation16 Mar 2026 - Strong FY2025 growth, margin expansion, and cash flow set up for accelerated 2026 performance.SN
Q4 20252 Mar 2026 - RISE strategy drives growth, innovation, and ASC leadership with strong financial targets for 2028.SN
CMD 20253 Feb 2026 - Q2 revenue up 5.6%, margin and cash flow improved, guidance and dividend maintained.SN
H1 20242 Feb 2026 - Q3 revenue up 4.0%, but China headwinds prompt lower 2024 margin and growth guidance.SN
Q3 2024 TU17 Jan 2026 - Q1 2025 revenue grew 3.1% with innovation and margin guidance unchanged despite headwinds.SN
Q1 2025 TU21 Dec 2025 - RISE strategy targets 6-7% revenue CAGR, >$1bn FCF, and innovation-led market leadership by 2028.SN
CMD 202512 Dec 2025 - Q3 2025 revenue grew 5% to $1.5bn, with margin and cash flow guidance raised for 2025.SN
Investor Presentation8 Dec 2025 - Strong H1 2025 growth, margin expansion, and $500m buyback announced; guidance reaffirmed.SN
H1 202523 Nov 2025